---
title: "BASECARE-B released its interim results, with a shareholder loss of 121 million yuan, an increase of 1.31% year-on-year"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/255225038.md"
description: "According to the Zhitong Finance APP, BASECARE-B announced its interim results for the six months ending June 30, 2025, with group revenue of RMB 101 million, a year-on-year decrease of 18.76%; the loss attributable to shareholders was RMB 121 million, a year-on-year increase of 1.31%; the loss per share was RMB 0.4"
datetime: "2025-08-29T13:36:06.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/255225038.md)
  - [en](https://longbridge.com/en/news/255225038.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/255225038.md)
---

# BASECARE-B released its interim results, with a shareholder loss of 121 million yuan, an increase of 1.31% year-on-year

According to the Zhitong Finance APP, BASECARE-B (02170) released its interim results for the six months ending June 30, 2025, with group revenue of RMB 101 million, a year-on-year decrease of 18.76%; the loss attributable to shareholders was RMB 121 million, a year-on-year increase of 1.31%; the loss per share was RMB 0.4

### Related Stocks

- [02170.HK](https://longbridge.com/en/quote/02170.HK.md)

## Related News & Research

- [Basecare Wins NMPA Class III Approval for Gems Embryo Culture Medium](https://longbridge.com/en/news/286258287.md)
- [Trump faces record-low approval on inflation as retirees struggle](https://longbridge.com/en/news/286834439.md)
- [09:06 ETHarmony Comes to the Massachusetts State House as The Platters® Prepare Their Musical Love Letter to the World](https://longbridge.com/en/news/286918739.md)
- [Mabwell Wins Wider China Indications for Denosumab Biosimilar as Global Push Accelerates](https://longbridge.com/en/news/287103520.md)
- [13:41 ETUT Haslam Marks Decade in Major International Ranking's Top Five U.S. Public Schools](https://longbridge.com/en/news/286804132.md)